In an experimental study we used a LOX-inhibitor (BAPN) in rats with implanted prostate tumors and found that LOX probably stimulated early tumor growth and conversely be inhibitory in already established tumors (Nilsson et al., unpublished). This evidence concerns the gene LOX and prostate neoplasm.